secwatch.observer — SEC 8-K summary
======================================

Issuer:     Edesa Biotech, Inc. (EDSA)
CIK:        0001540159
Form:       8-K
Filed at:   2022-03-04T23:59:59+00:00
Accession:  0001104659-22-030651
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Edesa Biotech amends equity distribution agreement with RBC for up to $15.4M ATM
--------------------------------------------------------------------------------

- Amended Equity Distribution Agreement with RBC Capital Markets to sell up to $15.4M additional common shares.
- Previously sold 487,228 shares for $2.5M under the prior agreement.
- Amendment enables ongoing at-the-market offerings through RBC as sales agent or principal.
- Legal opinion from Fasken Martineau DuMoulin LLP regarding share legality attached as exhibit.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1540159/000110465922030651/0001104659-22-030651-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1540159/000110465922030651/tm228418d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-22-030651

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer